← 治験一覧に戻る
閉鎖微小重力環境下における宇宙飛行士の免疫機能と腸内細菌叢に対するプロバイオティクスの影響
基本情報
- NCT ID
- NCT02618005
- ステータス
- 完了
- 試験のフェーズ
- 該当なし
- 試験タイプ
- 介入
- 目標被験者数
- 10
- 治験依頼者名
- Yakult Honsha Co., LTD
概要
Human immune function and intestinal microbiota are suggested to be altered within long-duration stay in space. Accumulated evidences on earth support that Lacticaseibacillus paracasei strain Shirota (LcS) is a promising probiotic strain on improvement of immune function and intestinal microbiota. This study aims to investigate the impact of long-duration spaceflight as well as intake of LcS on the international space station (ISS), on immune system and intestinal microbiota in astronauts.
対象疾患
Immune Function and Intestinal Microbiota
介入
Probiotic capsule(DIETARY_SUPPLEMENT)
依頼者(Sponsor)
ヤクルト本社(INDUSTRY)
実施施設 (1)
Japan Aerospace Exploration Agency
Ibaraki, Japan